Labcorp Holdings Future Growth
Future criteria checks 2/6
Labcorp Holdings is forecast to grow earnings and revenue by 19.4% and 4.7% per annum respectively. EPS is expected to grow by 21% per annum. Return on equity is forecast to be 16% in 3 years.
Key information
19.4%
Earnings growth rate
21.0%
EPS growth rate
Healthcare earnings growth | 19.3% |
Revenue growth rate | 4.7% |
Future return on equity | 16.0% |
Analyst coverage | Good |
Last updated | 21 Aug 2024 |
Recent future growth updates
Recent updates
Investors Still Waiting For A Pull Back In Labcorp Holdings Inc. (NYSE:LH)
Jul 20Laboratory Corporation: Limited Upside Visibility, Reiterate Hold
Jun 21When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Jun 13Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year
May 08Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 14,269 | 1,176 | 1,441 | 1,935 | 10 |
12/31/2025 | 13,677 | 1,044 | 1,061 | 1,535 | 14 |
12/31/2024 | 12,962 | 910 | 1,007 | 1,480 | 13 |
6/30/2024 | 12,488 | 450 | 962 | 1,496 | N/A |
3/31/2024 | 12,300 | 399 | 767 | 1,276 | N/A |
12/31/2023 | 12,162 | 379 | 874 | 1,328 | N/A |
9/30/2023 | 12,058 | 583 | 1,012 | 1,397 | N/A |
6/30/2023 | 11,868 | 677 | 1,008 | 1,372 | N/A |
3/31/2023 | 11,757 | 789 | 1,122 | 1,513 | N/A |
12/31/2022 | 11,864 | 1,002 | 1,417 | 1,847 | N/A |
9/30/2022 | 12,990 | 1,518 | 1,415 | 1,895 | N/A |
6/30/2022 | 14,186 | 1,829 | 1,788 | 2,303 | N/A |
3/31/2022 | 15,104 | 2,028 | 1,826 | 2,308 | N/A |
12/31/2021 | 13,136 | 2,195 | 2,597 | 3,018 | N/A |
9/30/2021 | 16,555 | 2,763 | 2,777 | 3,187 | N/A |
6/30/2021 | 16,388 | 2,879 | 2,836 | 3,206 | N/A |
3/31/2021 | 15,316 | 2,643 | 2,719 | 3,089 | N/A |
12/31/2020 | 13,979 | 1,556 | 1,754 | 2,135 | N/A |
9/30/2020 | 12,442 | 845 | 1,520 | 1,931 | N/A |
6/30/2020 | 11,475 | 362 | 1,174 | 1,600 | N/A |
3/31/2020 | 11,587 | 321 | 1,070 | 1,483 | N/A |
12/31/2019 | 11,555 | 824 | 1,045 | 1,445 | N/A |
9/30/2019 | 11,389 | 755 | 967 | 1,361 | N/A |
6/30/2019 | 11,292 | 853 | 758 | 1,158 | N/A |
3/31/2019 | 11,276 | 896 | 890 | 1,292 | N/A |
12/31/2018 | 11,333 | 884 | 926 | 1,305 | N/A |
9/30/2018 | 11,291 | 1,414 | 1,030 | 1,384 | N/A |
6/30/2018 | 11,081 | 1,266 | 1,198 | 1,529 | N/A |
3/31/2018 | 10,743 | 1,217 | N/A | 1,452 | N/A |
12/31/2017 | 10,308 | 1,227 | N/A | 1,498 | N/A |
9/30/2017 | 9,951 | 724 | N/A | 1,382 | N/A |
6/30/2017 | 9,702 | 732 | N/A | 1,235 | N/A |
3/31/2017 | 9,556 | 751 | N/A | 1,274 | N/A |
12/31/2016 | 9,553 | 712 | N/A | 1,197 | N/A |
9/30/2016 | 9,295 | 658 | N/A | 1,112 | N/A |
6/30/2016 | 9,192 | 633 | N/A | 1,150 | N/A |
3/31/2016 | 9,029 | 599 | N/A | 1,197 | N/A |
12/31/2015 | 8,506 | 438 | N/A | 982 | N/A |
9/30/2015 | 7,774 | 447 | N/A | 812 | N/A |
6/30/2015 | 7,056 | 430 | N/A | 699 | N/A |
3/31/2015 | 6,353 | 401 | N/A | 510 | N/A |
12/31/2014 | 6,012 | 511 | N/A | 739 | N/A |
9/30/2014 | 5,936 | 518 | N/A | 774 | N/A |
6/30/2014 | 5,846 | 529 | N/A | 833 | N/A |
3/31/2014 | 5,798 | 540 | N/A | 763 | N/A |
12/31/2013 | 5,808 | 574 | N/A | 819 | N/A |
9/30/2013 | 5,777 | 568 | N/A | 824 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LH's forecast earnings growth (19.4% per year) is above the savings rate (2.5%).
Earnings vs Market: LH's earnings (19.4% per year) are forecast to grow faster than the US market (15.2% per year).
High Growth Earnings: LH's earnings are forecast to grow, but not significantly.
Revenue vs Market: LH's revenue (4.7% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: LH's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LH's Return on Equity is forecast to be low in 3 years time (16%).